CTRI Number |
CTRI/2018/11/016395 [Registered on: 20/11/2018] Trial Registered Prospectively |
Last Modified On: |
16/11/2018 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda Dentistry |
Study Design |
Randomized, Parallel Group, Active Controlled Trial |
Public Title of Study
|
Herbal mouthwash for bleeding gums and plaque control |
Scientific Title of Study
|
A study validating the efficacy of a herbal mouthwash in reduction of plaque and gingivitis: An in vitro evaluation and a randomized controlled clinical trial |
Trial Acronym |
HMW in GI |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
O P Kharbanda |
Designation |
Professor and Head |
Affiliation |
All India Institute of Medical Sciences |
Address |
Division of Orthodontics and Dentofacial orthopedics
Centre for Dental Education and Research
All India Institute of Medical Sciences
South West DELHI 110029 India |
Phone |
9899062144 |
Fax |
|
Email |
opk15@hotmail.com |
|
Details of Contact Person Scientific Query
|
Name |
O P Kharbanda |
Designation |
Professor and Head |
Affiliation |
All India Institute of Medical Sciences |
Address |
Division of Orthodontics and Dentofacial orthopedics
Centre for Dental Education and Research
All India Institute of Medical Sciences South West DELHI 110029 India |
Phone |
9899062144 |
Fax |
|
Email |
opk15@hotmail.com |
|
Details of Contact Person Public Query
|
Name |
O P Kharbanda |
Designation |
Professor and Head |
Affiliation |
All India Institute of Medical Sciences |
Address |
Division of Orthodontics and Dentofacial orthopedics
Centre for Dental Education and Research
All India Institute of Medical Sciences
South West DELHI 110029 India |
Phone |
9899062144 |
Fax |
|
Email |
opk15@hotmail.com |
|
Source of Monetary or Material Support
|
National Innovation Foundation-India
Autonomous body of Department of Science and Technology, Govt. of India
Gandhinagar-382650, Gujrat, India |
|
Primary Sponsor
|
Name |
National innovation Foundation |
Address |
National Innovation Foundation-India
Autonomous Body of Department of Science and Technology, Govt. of India,
Gandhinagar - 382650, Gujarat, India
|
Type of Sponsor |
Government funding agency |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr O P Kharbanda |
Centre for Dental Education and Research |
Room No. 413, Division of Orthodontics, All India Institute of Medical Sciences South West DELHI |
9899062144
opk15@hotmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institute Ethics Committee |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: B998||Other infectious disease, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Chlorhexidine mouthwash |
Subjects will be given chlorhexidine mouthwash and asked to rinse for 2 min and expectorate. Subsequent to baseline estimation (set 1), each participant will undergo two sets of saliva sample collection along with estimation of salivary pH in two phases: Ten minutes after the mouthrinse (set 2), and 60 min after the mouthrinse (set 3) for salivary pH estimation.
Individuals will be instructed to use 15 ml mouthwash twice daily, 30 to 45 minutes after brushing.All examinations and scorings will be done under identical working conditions at baseline and days 7, 30, and 60. |
Intervention |
Herbal mouthwashes |
Subjects will be given the herbal mouthwash and asked to rinse for 2 min and expectorate. Subsequent to baseline estimation (set 1), each participant will undergo two sets of saliva sample collection along with estimation of salivary pH in two phases: Ten minutes after the mouthrinse (set 2), and 60 min after the mouthrinse (set 3) for salivary pH estimation. Individuals will be instructed to use 15 ml mouthwash twice daily, 30 to 45 minutes after brushing.All examinations and scorings will be done under identical working conditions at baseline and days 7, 30, and 60. |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
40.00 Year(s) |
Gender |
Both |
Details |
After taking a detailed medical history and initial clinical and radiologic examination, systemically healthy individuals of an age range of 18-40 years with previously untreated gingivitis and greater than or equal to 20 teeth with no visible signs of untreated dental caries will be selected. Clinical parameters for inclusion will be: 1) gingival index (GI) greater than 1; 2) probing depth less than equal to 3 mm; 3) clinical attachment loss should be 0, with no evidence of radiographic bone loss. Absence of bone loss will be considered when the distance between cemento-enamel junction and crestal bone is less than equal to 1 mm. |
|
ExclusionCriteria |
Details |
1) Use of antibiotics and anti-inflammatory drugs in previous 6 months; 2) individuals with orthodontic appliances or prosthetic appliances that would interfere with evaluation and plaque control; 3) allergy to any ingredient used in the study; 4) alcoholics; 5) smokers or users of tobacco in any form; 6) individuals with mental retardation or medical illness; 7) Use of mouthwashes and vitamin supplements in last 3 months; 8)History of any periodontal therapy in last months; and 7) pregnant or lactating females |
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
Blinding/Masking
|
Participant, Investigator and Outcome Assessor Blinded |
Primary Outcome
|
Outcome |
TimePoints |
Improvement of gingival and plaque indices |
Baseline, 1 week, 1 month, 2 months |
|
Secondary Outcome
|
Outcome |
TimePoints |
Microbial count. |
Baseline-7 days-30 days-60 days |
Patient acceptance (irritation of taste, subjective tooth staining) |
60 days |
|
Target Sample Size
|
Total Sample Size="120" Sample Size from India="120"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 1/ Phase 2 |
Date of First Enrollment (India)
|
01/01/2019 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
Not yet published
Publications which may arise
1. Effect of new herbal mouthwash on reduction of plaque and gingivitis: a randomized clinical trial
2. The effect of herbal mouthrinse on
Streptococcus mutans count and salivary pH:
An in vivo study
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
The aim of the present study is to evaluate the efficacy of herbal mouthwashes with chlorhexidine mouthwash in patients with mild to moderate gingivitis for reduction of plaque and gingivitis scores, Microbial counts and salivary pH reduction and to assess patient acceptance (irritation of taste, subjective tooth staining). One hundred twenty individuals with chronic generalized gingivitis will be randomly assigned to three groups: 1) group I, Chlorhexidine mouthwash; 2) group II, Herbal mouthwash A; and 3) group III, Herbal mouthwash B. All individuals will be instructed to rinse with 15 ml of their respective mouthwash twice daily. 1) plaque index (PI); 2) gingival index (GI); 3) oral hygiene index-simplified (OHI-S); and 4) microbiologic colony counts will be recorded at baseline and at 7, 30, and 60 days. Subsequent to baseline estimation (set 1), each participant will undergo two sets of saliva sample collection along with estimation of salivary pH in two phases: Ten minutes after the mouthrinse (set 2), and 60 min after the mouthrinse (set 3). |